论文部分内容阅读
卵巢癌临床分期对估计病人预后有很重要作用,按FIGO分期标准,肿瘤腹腔内转移为Ⅲ期。但临床上有些为镜下病理转移,有些为腹腔内粟粒状浸润灶,有的大面积侵犯腹腔脏器,这些不同程度的病变,对预后有不同结局。协和医院孙爱达等曾报道将卵巢癌分Ⅲa、Ⅲb亚期,其5年存活率有显著差异,我院在临床工作中体会到Ⅲ期再分期有一定意义,现将我院63例Ⅲ期卵巢上皮性癌各亚期的生存率及其与病理分级和手术切净率的关系分析报道如下。
Clinical staging of ovarian cancer plays an important role in estimating the prognosis of patients. According to the FIGO staging criteria, intra-abdominal tumor metastasis is stage III. However, some clinically pathological lesions for microscopic transfer, some for intraperitoneal miliary infiltration stove, and some large area violations of abdominal organs, these different degrees of disease, have different outcomes on the prognosis. Union Hospital, Sun Aida and other reports of ovarian cancer sub-Ⅲa, Ⅲ b sub-phase, the 5-year survival rate was significantly different from our hospital in clinical experience to stage Ⅲ stage of re-staging has some significance now in our hospital 63 cases of stage Ⅲ ovary Survival of epithelial cancer in each sub-phase and its relationship with the pathological grade and surgical resection rate are reported below.